Skip to main content
Premium Trial:

Request an Annual Quote

Roche to Sell Good Start Genetics' Carrier Screening Test Service

NEW YORK (GenomeWeb) – Good Start Genetics said today that it has partnered with Roche Diagnostics to sell its carrier screening service for inherited disorders.

Under the agreement, Roche Diagnostics will offer Good Start's GeneVu carrier screening test along with its own Harmony noninvasive prenatal fetal aneuploidy test, which was developed by Ariosa Diagnostics.

"The agreement with Good Start Genetics will enable Roche to offer a broader range of screening services to healthcare professionals who provide care for pregnant women and for parents involved in planning a family," Whitney Green, senior vice president of commercial operations at Roche Diagnostics, said in a statement, adding that GeneVu will complement the Harmony test.

Both GeneVu and Harmony are only available as laboratory-developed tests in the US and have not been approved by the US Food and Drug Administration.

The GeneVu test identifies carriers of a number of inherited genetic disorders. It comes in different versions and uses next-generation sequencing as its underlying technology.

The announcement of the marketing agreement comes about a month after Good Start Genetics said that it is selling its VeriYou test, which screens only for carriers of cystic fibrosis and spinal muscular atrophy, through Amazon.

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.